Atovaquone for Prophylaxis of Toxoplasmosis after Allogeneic Hematopoietic Stem Cell Transplantation

Publisher： Karger

E-ISSN： 1421-9662|134|3|146-154

ISSN： 0001-5792

Source： Acta Haematologica, Vol.134, Iss.3, 2015-05, pp. : 146-154

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effectiveness of antibacterial prophylaxis with non‐absorbable polymyxin B compared to levofloxacin after allogeneic hematopoietic stem cell transplantation

By  

TRANSPLANT INFECTIOUS DISEASE (ELECTRONIC), Vol. 1398-2273, Iss. 5, 2015-10 ,pp. : 647-654

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effectiveness of antibacterial prophylaxis with non‐absorbable polymyxin B compared to levofloxacin after allogeneic hematopoietic stem cell transplantation

By  

TRANSPLANT INFECTIOUS DISEASE (ELECTRONIC), Vol. 17, Iss. 5, 2015-10 ,pp. : 647-654

John Wiley & Sons Inc

Access to resources Recommend Favorite

Bullous pemphigoid after allogeneic hematopoietic stem cell transplantation

By  

PEDIATRICS INTERNATIONAL, Vol. 57, Iss. 3, 2015-06 ,pp. : 480-483

John Wiley & Sons Inc

Access to resources Recommend Favorite

Intestinal Pneumatosis Associated with Tuberculosis after Allogeneic Hematopoietic Stem Cell Transplantation

By  

Acta Haematologica, Vol. 137, Iss. 1, 2016-12 ,pp. : 51-54

Karger

Access to resources Recommend Favorite

Cost-effectiveness of primary antifungal prophylaxis with posaconazole versus itraconazole in allogeneic hematopoietic stem cell transplantation

By Sánchez-Ortega Isabel  

Journal of Medical Economics, Vol. 16, Iss. 6, 2013-06 ,pp. : 736-743

Informa Healthcare

Access to resources Recommend Favorite